References 9
Introduction
1.25 R.J. Ritchie, K. Guy, J.C. Philp: Policy to support marine biotechnology-based solutions to global challenges, Trends Biotechnol. 31, 128–131 (2013)
1.26 M.C. Alvarez, J. Bejar, S. Chen, Y. Hong: Fish ES cells
and applications to biotechnology, Mar. Biotechnol.
9, 117–127 (2007)
1.27 W. Fenical, P.R. Jensen: Developing a new resource
for drug discovery: Marine actinomycete bacteria,
Nat. Chem. Biol. 2, 666–673 (2006)
1.28 L. Bohlin, U. Göransson, C. Alsmark, C. Wedén,
A. Backlund: Natural products in modern life science,
Phytochem. Rev. 9, 279–301 (2010)
1.29 J.W. Blunt, B.R. Copp, R.A. Keyzers, M.H. Munro,
M.R. Prinsep: Marine natural products, Nat. Prod.
Rep. 30, 237–323 (2013)
1.30 R.A. Hill: Marine natural products, Annu. Rep. B (Organ. Chem.) 108, 131–146 (2012)
1.31 W.H. Gerwick, B.S. Moore: Lessons from the past and
charting the future of marine natural products drug
discovery and chemical biology, Chem. Biol. 19, 85–
98 (2012)
1.32 E. Fattorusso, W.H. Gerwick, O. Taglialatela-Scafati:
Handbook of Marine Natural Products (Springer, New
York 2012)
1.33 S. Agatonovic-Kustrin, D. Morton, C. Kettle: Structural
characteristics of bioactive marine natural products.
In: Marine Biomaterials: Characterization, Isolation,
and Applications, ed. by S.-K. Kim (Taylor Francis,
Boca Raton 2013)
1.34 A. Mayer, A.D. Rodríguez, R.G. Berlinck, N. Fusetani:
Marine pharmacology in 2007–8: Marine compounds
with antibacterial, anticoagulant, antifungal, antiinflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous
mechanisms of action, Comp. Biochem. Physiol. Part
C: Toxicol. Pharmacol. 153, 191–222 (2011)
1.35 M. Schumacher, M. Kelkel, M. Dicato, M. Diederich:
Gold from the sea: Marine compounds as inhibitors
of the hallmarks of cancer, Biotechnol. Adv. 29, 531–
547 (2011)
1.36 I. Orhan, B. Şener, M. Kaiser, R. Brun, D. Tasdemir:
Inhibitory activity of marine sponge-derived natural products against parasitic protozoa, Mar. Drugs 8,
47–58 (2010)
1.37 D.S. Dalisay, B.I. Morinaka, C.K. Skepper,
T.F. Molinski: A tetrachloro polyketide Hexahydro1H-isoindolone, Muironolide A, from the marine
sponge Phorbas sp. Natural products at the
nanomole scale, J. Am. Chem. Soc. 131, 7552 (2009)
1.38 P. Proksch, A. Putz, S. Ortlepp, J. Kjer, M. Bayer:
Bioactive natural products from marine sponges and
fungal endophytes, Phytochem. Rev. 9, 475–489
(2010)
1.39 I. Wijesekara, N.Y. Yoon, S.-K. Kim: Phlorotannins
from Ecklonia cava (Phaeophyceae): Biological activities and potential health benefits, Biofactors 36,
408–414 (2010)
1.40 N.L. Thakur, U. Hentschel, A. Krasko, C.T. Pabel,
A.C. Anil, W.E.G. Müller: Antibacterial activity of the
sponge Suberites domuncula and its primmorphs:
potential basis for epibacterial chemical defense,
Aquat. Microb. Ecol. 31, 77–83 (2003)
1.41 R. Solanki, M. Khanna, R. Lal: Bioactive compounds
from marine actinomycetes, Indian J. Microbiol. 48,
410–431 (2008)
1.42 R. Subramani, W. Aalbersberg: Marine actinomycetes: An ongoing source of novel bioactive
metabolites, Microbiol. Res. 167, 571–580 (2012)
1.43 S.V. Sperstad, T. Haug, H.-M. Blencke, O.B. Styrvold,
C. Li, K. Stensvåg: Antimicrobial peptides from marine invertebrates: Challenges and perspectives in
marine antimicrobial peptide discovery, Biotechnol.
Adv. 29, 519–530 (2011)
1.44 F.G. Camacho, J.G. Rodríguez, A.S. Mirón, M. Garcia,
E. Belarbi, Y. Chisti, E.M. Grima: Biotechnological significance of toxic marine dinoflagellates, Biotechnol. Adv. 25, 176–194 (2007)
1.45 J. Kennedy, N. O’Leary, G. Kiran, J. Morrissey,
F. O’Gara, J. Selvin, A. Dobson: Functional metagenomic strategies for the discovery of novel enzymes
and biosurfactants with biotechnological applications from marine ecosystems, J. Appl. Microbiol. 111,
787–799 (2011)
1.46 R.S. Rasmussen, M.T. Morrissey: Marine biotechnology for production of food ingredients, Adv. Food
Nutr. Res. 52, 237–292 (2007)
1.47 M. Venegas-Calerón, O. Sayanova, J.A. Napier: An
alternative to fish oils: Metabolic engineering of oilseed crops to produce omega-3 long chain polyunsaturated fatty acids, Prog. Lipid Res. 49, 108–119
(2010)
1.48 R. Tharanathan, K. Prashanth: Chitin/chitosan: modifications and their unlimited application potentialdan overview, Trends Food Sci. Technol. 18, 117–131
(2007)
1.49 J.-K. Francis Suh, H.W. Matthew: Application of
chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review, Biomaterials 21,
2589–2598 (2000)
1.50 G. Crini, P.-M. Badot: Application of chitosan, a natural aminopolysaccharide, for dye removal from
aqueous solutions by adsorption processes using
batch studies: A review of recent literature, Prog.
Polym. Sci. 33, 399–447 (2008)
1.51 M.L. Kang, C.S. Cho, H.S. Yoo: Application of chitosan
microspheres for nasal delivery of vaccines, Biotechnol. Adv. 27, 857–865 (2009)
1.52 S. Bahmani, G. East, I. Holme: The application of chitosan in pigment printing, Color Technol. 116, 94–99
(2000)
1.53 V. Morya, J. Kim, E.-K. Kim: Algal fucoidan: Structural and size-dependent bioactivities and their
perspectives, Appl. Microbiol. Biotechnol. 93, 71–82
(2012)
1.54 J. Venkatesan, S.-K. Kim: Chitosan composites for
bone tissue engineering—An overview, Mar. Drugs 8,
2252–2266 (2010)
1.55 T.H. Silva, A.R. Duarte, J. Moreira-Silva, J.F. Mano,
R.L. Reis: Biomaterials from marine-origin Biopoly-
Introduction
1.25 R.J. Ritchie, K. Guy, J.C. Philp: Policy to support marine biotechnology-based solutions to global challenges, Trends Biotechnol. 31, 128–131 (2013)
1.26 M.C. Alvarez, J. Bejar, S. Chen, Y. Hong: Fish ES cells
and applications to biotechnology, Mar. Biotechnol.
9, 117–127 (2007)
1.27 W. Fenical, P.R. Jensen: Developing a new resource
for drug discovery: Marine actinomycete bacteria,
Nat. Chem. Biol. 2, 666–673 (2006)
1.28 L. Bohlin, U. Göransson, C. Alsmark, C. Wedén,
A. Backlund: Natural products in modern life science,
Phytochem. Rev. 9, 279–301 (2010)
1.29 J.W. Blunt, B.R. Copp, R.A. Keyzers, M.H. Munro,
M.R. Prinsep: Marine natural products, Nat. Prod.
Rep. 30, 237–323 (2013)
1.30 R.A. Hill: Marine natural products, Annu. Rep. B (Organ. Chem.) 108, 131–146 (2012)
1.31 W.H. Gerwick, B.S. Moore: Lessons from the past and
charting the future of marine natural products drug
discovery and chemical biology, Chem. Biol. 19, 85–
98 (2012)
1.32 E. Fattorusso, W.H. Gerwick, O. Taglialatela-Scafati:
Handbook of Marine Natural Products (Springer, New
York 2012)
1.33 S. Agatonovic-Kustrin, D. Morton, C. Kettle: Structural
characteristics of bioactive marine natural products.
In: Marine Biomaterials: Characterization, Isolation,
and Applications, ed. by S.-K. Kim (Taylor Francis,
Boca Raton 2013)
1.34 A. Mayer, A.D. Rodríguez, R.G. Berlinck, N. Fusetani:
Marine pharmacology in 2007–8: Marine compounds
with antibacterial, anticoagulant, antifungal, antiinflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous
mechanisms of action, Comp. Biochem. Physiol. Part
C: Toxicol. Pharmacol. 153, 191–222 (2011)
1.35 M. Schumacher, M. Kelkel, M. Dicato, M. Diederich:
Gold from the sea: Marine compounds as inhibitors
of the hallmarks of cancer, Biotechnol. Adv. 29, 531–
547 (2011)
1.36 I. Orhan, B. Şener, M. Kaiser, R. Brun, D. Tasdemir:
Inhibitory activity of marine sponge-derived natural products against parasitic protozoa, Mar. Drugs 8,
47–58 (2010)
1.37 D.S. Dalisay, B.I. Morinaka, C.K. Skepper,
T.F. Molinski: A tetrachloro polyketide Hexahydro1H-isoindolone, Muironolide A, from the marine
sponge Phorbas sp. Natural products at the
nanomole scale, J. Am. Chem. Soc. 131, 7552 (2009)
1.38 P. Proksch, A. Putz, S. Ortlepp, J. Kjer, M. Bayer:
Bioactive natural products from marine sponges and
fungal endophytes, Phytochem. Rev. 9, 475–489
(2010)
1.39 I. Wijesekara, N.Y. Yoon, S.-K. Kim: Phlorotannins
from Ecklonia cava (Phaeophyceae): Biological activities and potential health benefits, Biofactors 36,
408–414 (2010)
1.40 N.L. Thakur, U. Hentschel, A. Krasko, C.T. Pabel,
A.C. Anil, W.E.G. Müller: Antibacterial activity of the
sponge Suberites domuncula and its primmorphs:
potential basis for epibacterial chemical defense,
Aquat. Microb. Ecol. 31, 77–83 (2003)
1.41 R. Solanki, M. Khanna, R. Lal: Bioactive compounds
from marine actinomycetes, Indian J. Microbiol. 48,
410–431 (2008)
1.42 R. Subramani, W. Aalbersberg: Marine actinomycetes: An ongoing source of novel bioactive
metabolites, Microbiol. Res. 167, 571–580 (2012)
1.43 S.V. Sperstad, T. Haug, H.-M. Blencke, O.B. Styrvold,
C. Li, K. Stensvåg: Antimicrobial peptides from marine invertebrates: Challenges and perspectives in
marine antimicrobial peptide discovery, Biotechnol.
Adv. 29, 519–530 (2011)
1.44 F.G. Camacho, J.G. Rodríguez, A.S. Mirón, M. Garcia,
E. Belarbi, Y. Chisti, E.M. Grima: Biotechnological significance of toxic marine dinoflagellates, Biotechnol. Adv. 25, 176–194 (2007)
1.45 J. Kennedy, N. O’Leary, G. Kiran, J. Morrissey,
F. O’Gara, J. Selvin, A. Dobson: Functional metagenomic strategies for the discovery of novel enzymes
and biosurfactants with biotechnological applications from marine ecosystems, J. Appl. Microbiol. 111,
787–799 (2011)
1.46 R.S. Rasmussen, M.T. Morrissey: Marine biotechnology for production of food ingredients, Adv. Food
Nutr. Res. 52, 237–292 (2007)
1.47 M. Venegas-Calerón, O. Sayanova, J.A. Napier: An
alternative to fish oils: Metabolic engineering of oilseed crops to produce omega-3 long chain polyunsaturated fatty acids, Prog. Lipid Res. 49, 108–119
(2010)
1.48 R. Tharanathan, K. Prashanth: Chitin/chitosan: modifications and their unlimited application potentialdan overview, Trends Food Sci. Technol. 18, 117–131
(2007)
1.49 J.-K. Francis Suh, H.W. Matthew: Application of
chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review, Biomaterials 21,
2589–2598 (2000)
1.50 G. Crini, P.-M. Badot: Application of chitosan, a natural aminopolysaccharide, for dye removal from
aqueous solutions by adsorption processes using
batch studies: A review of recent literature, Prog.
Polym. Sci. 33, 399–447 (2008)
1.51 M.L. Kang, C.S. Cho, H.S. Yoo: Application of chitosan
microspheres for nasal delivery of vaccines, Biotechnol. Adv. 27, 857–865 (2009)
1.52 S. Bahmani, G. East, I. Holme: The application of chitosan in pigment printing, Color Technol. 116, 94–99
(2000)
1.53 V. Morya, J. Kim, E.-K. Kim: Algal fucoidan: Structural and size-dependent bioactivities and their
perspectives, Appl. Microbiol. Biotechnol. 93, 71–82
(2012)
1.54 J. Venkatesan, S.-K. Kim: Chitosan composites for
bone tissue engineering—An overview, Mar. Drugs 8,
2252–2266 (2010)
1.55 T.H. Silva, A.R. Duarte, J. Moreira-Silva, J.F. Mano,
R.L. Reis: Biomaterials from marine-origin Biopoly-